Related Experiment Video
Updated: Mar 2, 2026
07:22
Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
3.5K
[Phage therapy: a realistic weapon against multidrug resistant bacteria]
Nicolas Dufour1, Laurent Debarbieux2
1Institut Pasteur, groupe interactions bactériophages bactéries chez l'animal, département de microbiologie, 25, rue du Docteur Roux, 75015 Paris, France - Centre hospitalier René Dubos, Service de réanimation médico-chirurgicale, 95500 Pontoise, France.
Medecine Sciences : M/S
|May 13, 2017
Summary
Antibiotic resistance is a growing threat, driving the search for alternative treatments like phage therapy. This review explores bacteriophages as a promising solution to combat drug-resistant bacteria.
Area of Science:
- Microbiology
- Infectious Diseases
- Therapeutics
Background:
- Rising rates of multidrug-resistant bacteria pose a significant global health challenge.
- The pipeline for novel antibiotics is insufficient to combat emerging resistance.
- Alternative treatment strategies are urgently needed.
Purpose of the Study:
- To review the challenges posed by multidrug-resistant bacteria.
- To explore bacteriophage biology and the potential of phage therapy.
- To discuss the applications, benefits, and limitations of phage therapy in humans.
Main Methods:
- Literature review of scientific publications on antibiotic resistance and phage therapy.
- Analysis of bacteriophage characteristics and mechanisms of action.
- Evaluation of existing and potential human applications of phage therapy.
Main Results:
- Bacteriophages are viruses that specifically infect and kill bacteria.
- Phage therapy offers a promising alternative to antibiotics for treating bacterial infections.
- Current research highlights the potential of phage therapy, alongside its limitations.
Conclusions:
- Phage therapy represents a viable and promising approach to combatting antibiotic-resistant infections.
- Further research and clinical trials are necessary to fully establish phage therapy's role in human medicine.
- Addressing regulatory and practical challenges is crucial for the widespread adoption of phage therapy.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
78.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.6K
01:26DNA Bacteriophages
1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.2K
01:31Defense Against Bacterial Pathogens
3.2K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.2K
00:43Lysogenic Cycle of Bacteriophages
68.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.3K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
02:53CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K